APA (7th ed.) Citation

Takahara, H., Kanazawa, T., Oshita, H., Tomita, Y., Hananoi, Y., Ishibashi, S., . . . Yamamoto, K. (2024). GPX4 and FSP1 Expression in Lung Adenocarcinoma: Prognostic Implications and Ferroptosis-Based Therapeutic Strategies. Cancers, 16(22), 3888. https://doi.org/10.3390/cancers16223888

Chicago Style (17th ed.) Citation

Takahara, Hirotomo, et al. "GPX4 and FSP1 Expression in Lung Adenocarcinoma: Prognostic Implications and Ferroptosis-Based Therapeutic Strategies." Cancers 16, no. 22 (2024): 3888. https://doi.org/10.3390/cancers16223888.

MLA (9th ed.) Citation

Takahara, Hirotomo, et al. "GPX4 and FSP1 Expression in Lung Adenocarcinoma: Prognostic Implications and Ferroptosis-Based Therapeutic Strategies." Cancers, vol. 16, no. 22, 2024, p. 3888, https://doi.org/10.3390/cancers16223888.